Every cancer diagnosis begins a deeply personal journey, one shaped by both the disease itself and the individual. Cancer ...

TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...

What are the benefits and challenges of using multiomics approaches to discover cancer biomarkers? Multiomics means that scientists are measuring more than one class of analyte, such as DNA, RNA, or ...

Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), ...

Please provide your email address to receive an email when new articles are posted on . Machine learning models can predict which patients receiving lung cancer therapy may need urgent care visits.

Machine learning and other forms of artificial intelligence have already been repeatedly proven to deliver faster, more consistent diagnoses than human physicians, but they may increase overdiagnosis ...

The evidence isn't there yet for routine use, but Michael Leapman, MD, urologic oncologist and associate professor of oncology at Yale School of Medicine, discusses what the future may hold for ...

Rectal cancer is occurring earlier and killing younger adults faster, according to a study presented at Digestive Disease Week 2026, held from May 2 to 5 in Chicago. Mythili Menon Pathiyil, MD, from ...